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Abstract
The goal of this study was to follow a cohort of patients undergoing total knee arthroplasty over time to: (1) identify and describe the
various pain trajectories beginning preoperatively and for up to 12 months after surgery, (2) identify baseline predictors of trajectory
group membership, and (3) identify trajectory groups associated with poor psychosocial outcomes 12 months after surgery. One
hundred seventy-three participants (female 5 85 [49%]; mean age [years] 5 62.9, SD 5 6.8) completed pain and psychological
questionnaires and functional performance tests preoperatively and 4 days, 6 weeks, and 3 and 12 months after total knee
arthroplasty. Using growth mixture modeling, results showed that a 4-group model, with a quadratic slope and baseline pain data
predicting trajectory group membership, best fit the data (Akaike information criterion 5 2772.27). The first 3 pain trajectories
represent various rates of recovery ending with relatively low levels of pain 12 months after surgery. Group 4, the constant high pain
group, comprises patients who have a neutral or positive pain slope and do not show improvement in their pain experience over the
first year after surgery. This model suggests that preoperative pain levels are predictive of pain trajectory group membership and
moderate preoperative pain, as opposed to low or high pain, is a risk factor for a neutral or positive pain trajectory postoperatively.
Consistent with previous studies, these results show that postoperative pain is not a homogeneous condition and point to the
importance of examining intraindividual pain fluctuations as they relate to pain interventions and prevention strategies.
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1. Background
Chronic postsurgical pain (CPSP) is a prevalent pain condition that
affects between 1.5%and10%of adults one year after undergoing
surgery.30 Chronic postsurgical pain is typically defined as
persistent pain that continues for longer than 2 months after
surgery and cannot be attributed to a preexisting pain condition or
causes other than surgery.39 A significant proportion of patients,
however, undergo surgery with one of the goals being a reduction
in their preexisting pain. Total knee arthroplasty (TKA) is one such
example. Total knee arthroplasty is a surgical procedure that is
often preceded bymoderate to severe pain, which has a significant
impact on rehabilitation and hospital discharge. A large proportion
of patients continue to experience pain after TKA.11
Acute postoperative pain is one of the most consistent
predictors of the development of CPSP or continuation of the
pain experience.28,29,31,48 However, not all patients with
moderate/severe acute postoperative pain will develop CPSP.
Examining risk factors (eg, single pain intensity score) without
considering rates of postoperative pain resolution limits the
effectiveness of prevention and treatment approaches.14 In
addition, the development of chronic pain is a dynamic process
in which the progression from acute to chronic pain is as
important as the maintenance of chronic pain.28 Examining pain
as it evolves over time (ie, along a time continuum) as opposed to
at discrete time points will contribute to identifying broader causal
and associative risk factors that are involved in the development
and maintenance of chronic pain.28,36
The examination of pain trajectories not only improves detection
of problematic pain outcomes but also improves precision of pain
measurement.14 This approach can provide valuable information
to help identify patients whose postoperative pain follows a favor-
able path to recovery vs patients whose pain remains stable or
worsens and eventually transitions into CPSP.15,55
Chapman et al.14 examined individual pain trajectories in the
first 6 days after surgery and found 3 distinct patient groups:
negative pain slope, stable pain slope, and increased pain
slope.14 Similar results were obtained in a sample of adults
undergoing cardiac surgery.16 Another study of pain trajectories
of liver donor patients showed that patients who developedCPSP
had higher pain intensity trajectories in the first 24 hours after
surgery or an abnormal resolution of their acute pain.10
The goals of this study were to: (1) identify and describe the
various pain trajectories beginning preoperatively and for up to
12 months after surgery, (2) identify baseline predictors of
trajectory group membership, and (3) identify trajectory groups
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that are associated with poor psychosocial outcomes 12 months
after surgery in a cohort of patients undergoing TKA.
The prevalence rate of TKAs varies between 8.6 (Romania) and
213.3 (United States) per 100,000 population,34 with an average
hospital length stays of 7.7 days.38 Osteoarthritis, the primary
reason for TKA, is associated with mobility difficulties.22,25 As
such, this study will examine the presence of CPSP after TKA and
functional outcomes.
2. Methods
2.1. Participants
Adults between the ages of 18 and 75 years with an American
Society of Anesthesiology physical status I to III and scheduled to
undergo unilateral TKA were eligible to participate in this study.
Patients were excluded from this study if they had a history of
drug or alcohol abuse, had a known allergy to medications being
used in this study, had chronic pain on slow-release preparations
of opioid, had rheumatoid arthritis, had a history of psychiatric
disorders, were unable to use patient-controlled analgesia, were
diabetic or had impaired renal function, or had a bodymass index
greater than 40. Patients were excluded postoperatively if they
had additional operative procedures requiring modification of the
usual rehabilitation standard of care.
2.2. Questionnaires
2.2.1. Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC LK3.1)
The WOMAC is a 24-item Likert scale that assesses the extent to
which patients with knee and/or hip osteoarthritis experience pain,
stiffness, and physical functional impairment.3,4 The WOMAC
comprises 3 subscales, namely pain (5 items), stiffness (2 items),
and physical function (17 items). For each item, patients are asked to
rate the extent to which they experience pain, stiffness, and physical
limitations on a scale ranging from 0 (none) to 4 (extreme). Total
scores range from 0 to 20 for the pain subscale, 0 to 8 for the
stiffness subscale, and0 to 68 for thephysical function subscalewith
higher scores indicating worse pain, stiffness, and physical
limitations. The WOMAC subscales have very good internal
consistency (a 5 0.86-0.95),5 adequate test–retest reliability (intra-
class correlation coefficient 5 0.74-0.95),21,52 good sensitivity and
responsiveness to change over time,12,40,59 and adequate face,4
construct,9,12,53 and criterion9,13,51 validity. The WOMAC subscale
has adequate reliability (a50.84) tomeasurepain related tophysical
functioning and correlatesmoderately with the visual analog scale.24
2.2.2. Lower Extremity Functional Scale
The Lower Extremity Functional Scale is a 20-item Likert scale
that assesses a patient’s difficulties to perform everyday tasks
because of his or her knee problem.6 For each item, patients are
asked to rate the extent to which they are having difficulties
performing the tasks using a scale from 0 (extreme difficulty or
unable to perform activity) to 4 (no difficulty). Total scores range
from 0 to 80 with lower scores indicating greater lower extremity
impairment. The Lower Extremity Functional Scale has good
test–retest reliability (r 5 0.94), sensitivity to change, and
adequate convergent and discriminant validity.6,60
2.2.3. Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale (HADS) is a 14-item
Likert scale that assesses an individual’s levels of depression
(7-item subscale) and anxiety (7-item subscale) in nonpsychiatric
hospital patients (physical symptoms of anxiety and disorders,
such as fatigue, dizziness, and insomnia, are excluded).61 For
each item, patients are asked to check the answer that most
closely describes how they have been feeling in the past week on
a scale from 0 to 3. Total scores for each subscale range from 0 to
21 with higher scores indicating higher levels of anxiety or
depression. The internal consistency of the depression (a5 0.67-
0.90) and anxiety (a 5 0.68-0.93) subscales of the HADS is
adequate.7 The HADS also has good discriminant and conver-
gent validity as well as specificity and sensitivity in detecting
clinically significant levels of depression and anxiety.7
2.2.4. Pain Disability Index
The Pain Disability Index (PDI) is a 7-item scale that measures the
extent to which pain is interfering with everyday tasks (family and
home responsibilities, recreation, social activity, occupation, sexual
behavior, self-care, and life-support activity).49 Patients answer
each itemon a scale from0 (nodisability) to 10 (worst disability) with
total scores ranging from 0 to 70, higher scores indicating higher
levels of pain-related disability. The Pain Disability Index has
adequate internal consistency (a 5 0.86), fair test–retest reliability
(r 5 0.44), and adequate concurrent validity.17,49,56,57
2.3. Functional outcomes
The timed get up and go test (TUG), 6-minute walk test, and the
stair test were used to evaluate functional performance. These
measures have shown to have adequate reliability and sensitivity
to change over time in an arthroplasty population.33
2.3.1. Timed get up and go test
Patients are asked to rise from a standard arm chair, walk at
a safe and comfortable pace for 3 m, and then return to a sitting
position in the chair.23,45 Length of time to complete the test, use
of armrest to get up and sit down, and pain intensity at the site of
surgery were recorded.
2.3.2. Six-minute walk test
Patients are asked to walk to cover as much distance as possible
during 6 minutes, with the possibility to stop and rest as needed
during the test.8,35,47 Standardized encouragement is offered
every 60 seconds as research has shown that encouragement
improves performance.26 Total distance walked, test completion,
and pain intensity at the site of surgery were recorded.
2.3.3. Stair test
Patients are asked to ascend and descend 1 flight of 9 stairs in
their usual manner, at a safe and comfortable pace.32,58 Test
completion, length of time to complete the test, aids used
(crutches, cane, railing), ascending and descending pattern, and
pain intensity at the site of surgery were recorded.
2.3.4. Knee range motion
Active assisted knee flexion and active knee extensions were
recorded. As soon as the measurement of knee flexion is
complete, patients are asked to rate the intensity of their pain.
Knee range motion has been shown to have good reliability
among patients with knee osteoarthritis.33
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2.4. Procedure
The study was approved by the Research Ethics Board of the
Sunnybrook Hospital Health Sciences Center. Eligible partic-
ipants were recruited from the preassessment clinic or the
preoperative rehabilitation education session and provided
written and informed consent. Data from the first 3 months of
this analysis were part of a randomized controlled trial18
examining the effect of perioperative gabapentin use on re-
habilitation outcomes, functional status, and evoked pain. A
separate Research Ethics Board (REB) submissionwas approved
by the REB to gather postoperative pain data from these
participants 1 year after surgery. Preoperatively, participants
received either 400mg of celecoxib and 600mg of gabapentin or
400 mg of celecoxib and a placebo. Postoperatively, all
participants, regardless of treatment group, received a standard
postoperative regimen of celecoxib 200 mg b.i.d. for 3 days and
were given intravenous patient-controlled analgesia with mor-
phine for the first 24 hours. Participants also received either
placebo or gabapentin 200mg t.i.d. as per randomization starting
8 hours after the preoperative dose and continuing for 4 days.
Participants completed a series of questionnaires and functional
performance measures preoperatively and postoperatively on
days 1 to 4, and at 6 weeks and 3months. One year after surgery,
patients were contacted and the full series of questionnaires was
completed over the phone. Physical function data were not
collected at this point. Details and time of administration of
questionnaires and functional performance tests performed are
shown in Table 1.
2.5. Data analysis
2.5.1. Pain trajectories
Pain trajectory analyses were performed using growth mixture
modeling (GMM).2,42,43 Growth mixture modeling is a longitudinal
analysis methodology in which a latent membership to discrete
trajectories is estimated. Mixture refers to the use of categorical
(discrete) and continuous variables, either as observed or latent.
Growth mixture modeling allows for individual variation within
trajectory groups, which is defined as random effects as in
longitudinal data analysis with continuous variables. Mplus
(Version 7, Muthen & Muthen, Los Angeles, CA)44 was used to
test several models in which number of groups and model
structure were evaluated empirically. Scores on the pain subscale
of the WOMAC collected at a total of 5 time points were used to
estimate pain trajectories. The 2 main aspects that varied across
models were the role of the baseline WOMAC pain score and the
inclusion of a quadratic term into the longitudinal measurement
portion of the model. Akaike Information Criterion (AIC)1,20 was
used to determine the best model fit. Lower AIC values are
associated with better fit to the data. In addition, model selection
should also be determined by interpretability of the resulting
membership groups, not unlike the practice in factor analysis.37
Pearson x2 test was used to examine differences in pain trajectory
groupmembership across randomization conditions (gabapentin
vs placebo), and if a significant difference was found this variable
was entered in the pain trajectory model.
2.5.2. Differences in pain, psychological, and functional
outcomes based on pain trajectory group membership
When appropriate, analyses compared the treatment and
placebo groups to rule out group differences before analyzing
the sample as a whole.
Pearson x2 test examined differences in the presence/absence
of pain at the surgery site 12 months after surgery across
trajectory group membership. Univariate 1-way analysis of
variance (ANOVA) was used to examine differences in average
pain intensity (Numeric Rating Scale [NRS]) at 12 months across
trajectory group membership. Alpha level was set at 0.025 to
control for multiple comparisons.
Univariate 1-way ANOVA examined differences in baseline
pain levels (WOMAC–Pain) across trajectory group.
Multivariate ANOVAs were used to examine differences in
trajectory group membership in levels of: (1) anxiety,
depression, lower-extremity functioning, stiffness, functioning
difficulty, and pain disability (12 months only) at baseline and
12 months after surgery, (2) functional performance outcome
measures (distance completed during the 6-minute walk test,
time to complete the TUG test, time to complete stair test) at
baseline, and (3) assisted knee flexion and knee extension at
baseline. Significant overall models (a 5 0.017 to account for
multiple comparisons) were followed up with Bonferroni post
hoc tests.
2.6. Sample size estimation
Sample size was estimated a priori for Pearson x2 test, 2-tailed
multivariate ANOVA, and univariate 1-way ANOVA using
G*Power (version 3.1; G*Power Team, Dusseldorf, Germany).
There are no general rules on minimum sample size required for
GMM; sample size requirements will depend on theoretical
foundations of the study, data characteristics, models being
tested, between-group differences, and reliability of measure-
ment.50 Simulation data suggest that sample sizes of 200
participants with 5 time points offer a power greater than
80%.27
Sample size estimation for Pearson x2 test showed that
a sample size of 122 participants would be required to detect
a medium effect size (w5 0.3) with a5 0.05, power5 80%, and
df 5 3. Sample size estimation showed that 152 participants
would be required for a univariate 1-way ANOVA to ensure a 5
0.025, power 5 80% with a medium effect size (f 5 0.3), and 4
groups. Sample size estimation for multivariate ANOVA showed
Table 1
Details and timing of administration of questionnaires and
functional performance tests.
Baseline POD1 POD2 POD3 POD4 6
wk
3
mo
12
mo
Questionnaires
WOMAC √ √ √ √ √
HADS √ √ √ √ √
LEFS √ √ √ √ √
PDI √
Knee arthroplasty
pain questionnaire
√
Functional
performance tests
Timed get up and go
test
√ √ √ √ √
Stair test √ √ √ √
6-minute walk test √ √ √
Range of motion √ √ √ √ √ √ √
HADS, Hospital Anxiety and Depression Scale; LEFS, Lower Extremity Function Scale; PDI, Pain Disability
Index; range of motion: assisted active knee flexion and active knee extension; WOMAC, Western Ontario and
McMaster Universities Osteoarthritis Index.
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that a sample size of 40 participants would be required to detect
a medium effect size (v 5 0.25) with a 5 0.017, power 5 80%,
number of groups 5 4, and with 6 response variables.
3. Results
3.1. Recruitment
Recruitment took place between November 2007 and March
2012. Details of the recruitment process and patient retention are
presented in Figure 1.
There were no significant differences in baseline measures of
anxiety, depression, or lower-extremity function between
patients who completed vs those who did not complete the
postoperative day 4 (POD4) assessment, 6-week follow-up,
3-month follow-up, or 12-month follow-up. Patients who
completed the POD4 assessment walked a significantly greater
distance on the 6-minute walk test at baseline (P 5 0.027) and
reported significantly less pain intensity (P 5 0.038) after the
knee flexion test at baseline compared with patients who did
not complete the POD4 assessment. There were no other
statistically significant differences in pain intensity scores during
functional tests between those who completed the POD4
assessment vs patients who did not complete the POD4
assessment. Patients who completed the 6-week follow-up
walked a significantly greater distance on the 6-minute walk test
(P5 0.027) and took significantly less time to complete the stairs
test (P 5 0.040) at baseline compared with patients who did
not complete the 6-week follow-up. Patients who completed
the 3-month tests climbed a significantly greater number of
stairs (P 5 0.015) at baseline compared with patients who did
not complete the 3-month follow-up.
3.2. Descriptive statistics
The final sample comprised 173 adults (female 5 85 [49%]) aged
between 37 and 76 years (mean age in years 5 62.9, SD 5 6.8).
Four participants (2.3%) had previously undergone foot/ankle
surgery, 61 participants (35.3%) had previously undergone lower-
extremity surgery, and 25 participants (14.5%) had previously
undergone TKA. Twenty-three (21.3%) of the participants who
completed the 12-month follow-up underwent another surgical
procedure in the first 12months after the present surgery, but none
of these 23 patients had another surgery at the site of the TKA.
Overall, patients in this sample reported gradually decreasing
pain from baseline (WOMAC–pain mean 5 9.81; SD 5 3.1) to
4 days (WOMAC–pain mean 5 8.36; SD 5 3.1) and 6 weeks
(WOMAC–pain mean 5 6.76; SD 5 3.2) after surgery; the pain
intensity sharply decreased from 6 weeks to 3 (WOMAC–pain
mean5 3.84; SD5 3.3) and 12 months (WOMAC–pain mean5
2.54; SD 5 3.3) after surgery.
Mean and SD values for questionnaires and functional
performance tests are presented in Table 2 and pain outcomes
at the 12-month follow-up are presented in Table 3.
3.3. Pain trajectories
Eight different models were tested based on different
combinations of the following factors: (1) baseline data used
either as the initial time point of the trajectory or not in the
trajectory itself but rather as a predictor of trajectory group
membership, (2) presence or absence of a quadratic slope,
and (3) 3 or 4 trajectory group memberships. The number of
groups tested was between 3 and 4 as other options produced
large errors of estimation. Table 4 shows the characteristics of
these 8 models.
The final model (based on the lowest AIC value) comprised 4
groups, used baseline data as a predictor of trajectory group
membership, and included a quadratic slope. The use of baseline
data as a predictor, rather than as part of the trajectory,makes the
trajectory group membership statistically independent of pre-
operative pain level. Five participants were excluded from the final
model because they did not have baseline data. The structure of
the final model is illustrated in Figure 2 and the characteristics
and parameter estimates of the regression equation for each
group are shown in Table 5.
Pearson x2 test showed no significant differences between the
control and gabapentin groups in pain trajectory group member-
ship (P 5 0.715) and as such group randomization (placebo vs
gabapentin) was not entered as a variable in the trajectory model.
The pain trajectories of the 4 groups are shown in Figure 3.
Group 1 (n 5 27), named high baseline pain early and late
decrease group, is characterized by high preoperative pain
intensity, lower acute postoperative pain intensity that remains
Figure 1. Details of recruitment process.
Figure 2.Representation of the final growthmixturemodel. Baseline is used as
a predictor of trajectory group membership and a quadratic slope is added.
The latent trajectory group membership is tested using 4 different groups. BL,
baseline; 4D, 4 days postoperatively; 6W, 6-week follow-up; 3M, 3-month
follow-up; 12M, 12-month follow-up; I, intercept; L, linear slope; Q, quadratic
slope; C, latent group membership based on longitudinal measurement
model.
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constant up to 3months after surgery, and then shows a second
drop in pain intensity at 12 months after surgery. Group 2 (n 5
66), named low baseline pain gradual decrease group, is
characterized by a relatively low level of preoperative pain that
remains constant across the first few days after surgery and
subsequently gradually decreases up to 12 months after
surgery. Group 3 (n 5 60), named high baseline pain gradual
decrease group, is characterized by a higher level of pre-
operative pain compared with group 2. Patients in this group
reported a lower level of pain in the first 4 days after surgery
compared with their baseline pain level, and this decrease
continued up to 12 months after surgery. Group 4 (n 5 15),
named high pain group, is characterized by moderate levels of
pain preoperatively and relatively constant pain of moderate
intensity up to 12 months after surgery.
Unlike patients in groups 1 to 3 who show a decrease in pain
levels over time (negative slopes), patients in group 4 have
a neutral or positive pain slope and do not show a decrease in
pain over time. There were no significant age (P 5 0.149) or
gender (P5 0.064) differences between patients in the 4 different
pain trajectories.
3.4. Differences in pain, psychological, and functional
outcomes based on pain trajectory group membership
Results of Pearson x2 test (see Table 3 for additional details)
showed significant differences in the presence of pain at the
surgery site in the week before the 12-month follow-up across
pain trajectories: A significantly smaller proportion of patients in
group 2 reported the presence of pain 12 months after surgery in
contrast to group 4 where a significantly greater proportion
reported pain 12months after surgery. In addition, 1-way ANOVA
showed significant differences in average pain intensity 12
months after surgery (F(3,73)5 5.24, P5 0.002) across trajectory
group membership such that patients in group 4 reported higher
average pain intensity compared with patients in group 2 (NRS
mean difference 5 2.87, P 5 0.001) and group 3 (NRS mean
difference 5 2.24, P 5 0.016).
Given the number of participants per trajectory groupmember-
ship in the final model (27, 66, 60, and 15, respectively), the GMM
model was unable to estimate all necessary parameters when the
relationships between pain trajectories and psychological and
functional variables were entered. As such, these relationships
were explored separately through ANOVAs.
Table 2
Mean (SD) values of pain, psychological variables, and functional performance outcomes measured preoperatively, 4 d, 6 wk, 3
mo, and 12 mo after surgery.
Baseline POD4 6 wk 3 mo 12 mo
Pain outcomes
WOMAC–Pain* 9.80 (3.2) 8.36 (3.1) 6.76 (3.2) 3.84 (3.3) 2.55 (3.3)
Stair test–Pain* 4.49 (2.4) 4.15 (2.4) 2.50 (2.0) 1.46 (1.7)
TUG test–Pain* 3.33 (2.4) 4.27 (2.3) 1.83 (1.9) 0.79 (1.3)
Walk test–Pain* 5.21 (2.3) 2.91 (2.1) 1.33 (1.8)
Knee flexion–Pain* 4.19 (2.1) 5.59 (2.6) 2.42 (1.9) 1.19 (1.8)
Psychological and functional variables
HADS–anxiety 5.92 (3.5) 5.49 (3.1) 4.75 (3.5) 3.68 (3.0) 3.64 (3.2)
HADS–D 4.31 (2.6) 4.64 (3.0) 4.01 (2.9) 5.38 (2.3) 2.71 (2.9)
WOMAC–stiffness 4.51 (1.6) 4.22 (1.3) 3.38 (1.5) 2.39 (1.5) 1.59 (1.5)
WOMAC–difficulty 33.51 (11.1) 34.49 (9.4) 22.02 (12.2) 14.43 (11.3) 9.40 (11.4)
LEFS 29.18 (11.5) 17.55 (11.4) 35.59 (16.2) 48.40 (14.3) 22.03 (15.7)
PDI 9.13 (13.4)
Assisted knee flexion 86.10 (10.8)
Assisted knee extension 3.65 (3.1)
* Pain intensity measured using the 11-point Numeric Rating Scale.
HADS-Anxiety, Hospital Anxiety and Depression Scale—Anxiety Subscale; HADS-D, Hospital Anxiety and Depression Scale—Depression Subscale; LEFS, Lower Extremity Function Scale; PDI, Pain Disability Index; TUG, timed
get up and go test; WOMAC–difficulty, Western Ontario and McMaster Universities Osteoarthritis Index—difficulty subscale; WOMAC–Pain, Western Ontario and McMaster Universities Osteoarthritis Index—Pain subscale;
WOMAC–stiffness, Western Ontario and McMaster Universities Osteoarthritis Index—stiffness subscale.
Table 3
Pain outcomes at the 12-mo follow-up across pain trajectory classes and for the total sample.
Pain trajectory classes Total sample x2 P
High baseline pain, early
and late decrease
Low baseline pain,
gradual decrease
High baseline pain,
gradual decrease
Constant high pain
Ever feel pain (n) Yes 6 18† 20* 8* 54 5.72 0.126
No 9 23* 14† 2† 50
Had pain in last wk (n) Yes 4 9† 8 7* 29 8.45 0.038
No 13 32* 27 4† 79
Pain right now (n) Yes 2 0† 3 4* 9 14.78 0.002
No 15 41* 32 7† 99
Pain trajectory classes Total
sample
F (df) P
High baseline pain,
early
and late decrease
Low baseline pain, gradual
decrease
High baseline pain, gradual
decrease
Constant high
pain
Average pain intensity
(mean, (SD))
2.50 (2.7) 1.77 (1.5) 2.39 (1.9) 4.64 (2.7) 2.52 (2.2) 5.24 (3, 73) 0.002
* Fewer patients than expected by chance endorsed this category.
† More patients than expected by chance endorsed this category.
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3.5. Group differences in baseline variables
Mean valueson thepsychological and functional outcomemeasures
across trajectory group membership are shown in Table 6.
One-way ANOVA showed significant differences between pain
trajectory groups in baseline pain levels (F(3,164) 5 82.44, P ,
0.001). Bonferroni post hoc analyses showed that patients in
group 4 had significantly lower pain scores compared with
patients in group 1 (P 5 0.001) and significantly higher pain
scores compared with patients in group 2 (P , 0.001).
Multivariate ANOVA (F(15,459) 5 5.48, P , 0.001) showed
significant differences among pain trajectory groups in baseline
levels of anxiety (F(3,155) 5 5.54, P 5 0.001), stiffness (F(3,155) 5
11.42, P , 0.001), functional difficulty (F(3,155) 5 24.90, P ,
0.001), and lower-extremity functioning (F(3,155) 5 13.65, P ,
0.001) but not depression (P5 0.099). Table 6 shows mean and
SD values on all measures across pain trajectory groups at
baseline and 12 months after surgery. Bonferroni post hoc tests,
comparing group 4 with the other 3 groups showed that group 4
had significantly poorer lower-extremity functioning (P 5 0.020),
higher anxiety scores (P5 0.006), and higher levels of functioning
difficulty (P 5 0.001) compared with group 2.
Multivariate ANOVA (F(9,462) 5 3.36, P 5 0.001) showed an
overall significant difference in functional performance outcomes
at baseline (time to complete stair test, time to complete TUG test,
and total distance walked in 6-minute walk test) across groups.
Bonferroni post hoc tests, comparing group 4 with the other 3
groups, showed that patients in group 4 took significantly longer
period to complete the stairs test compared with patients in group
2 (mean difference5 10.11, P 5 0.004).
Multivariate ANOVA (F(6,258) 5 1.23, P 5 0.291) showed no
significant differences in knee flexion and knee extension at
baseline across groups.
3.6. Group differences in 12-month variables
Multivariate ANOVA (F(18,231) 5 4.52, P , 0.001) showed
significant difference between pain trajectory groups in 12-
month levels of depression (F(3,80) 5 5.36, P 5 0.002), anxiety
(F(3,80) 5 3.06, P 5 0.033), stiffness (F(3,80) 5 9.84, P , 0.001),
functional difficulty (F(3,80) 5 28.56, P , 0.001), lower-extremity
functioning (F(3,80)5 11.01, P, 0.001), and pain disability (F(3,80)
5 6.71, P, 0.001). Bonferroni post hoc tests, comparing group
4with the other 3 groups showed that group 4 had significantly (1)
worse lower-extremity functioning compared with group 2 (P ,
0.001) and group 3 (P , 0.001), (2) higher levels of stiffness
compared with group 1 (P 5 0.002), group 2 (P , 0.001), and
group 3 (P , 0.001), (3) higher levels of functioning difficulty
compared with group 1 (P , 0.001), group 2 (P , 0.001), and
group 3 (P , 0.001), and (4) higher levels of pain disability
compared with group 2.
4. Discussion
The aims of this study were to examine pain trajectories over
the first 12 months after TKA and to identify predictors of pain
trajectory group membership. Results showed that a 4-group
model with a quadratic slope and with baseline data as
predictor of trajectory group membership had the best fit to the
data. Consistent with previous studies,14,36,55 these results
show that postoperative pain is not a homogeneous condition
and point to the importance of examining intraindividual
postoperative pain fluctuations. This model also indicated that
preoperative pain levels are predictive of pain trajectory group
membership. The present results suggest that moderate
preoperative pain, as opposed to low or high pain, is one of
the risk factors for a poorer pain trajectory postoperatively and
a poorer pain status outcome 12 months after surgery. These
results are consistent with another study examining acute pain
trajectories in patients undergoing TKA. Morze et al.41 found
the presence of 4 different pain trajectories in the first 3 months
after TKA; preoperative “best” and “worst” pain scores#4 of 10
were a risk factor for initially higher postoperative pain, slower
rates of pain decline, and a longer time to experience a 50%
reduction in pain scores.
Previous research has shown that acute postoperative pain
intensity scores predict the development of CPSP.28,29,31,48
Results from this study provide a more refined view of the role of
acute postoperative pain in the development of CPSP. Results
from this study showed that patients in groups 1 to 4 had similar
levels of acute postoperative pain 4 days after surgery; however,
only patients in group 4 continued to experience similar levels of
pain 12 months after surgery. What seems to differentiate
patients in group 4 from the other groups is that these patients
on average did not report a change in their pain score from
baseline to the first 2 postoperative time points (4 days and
6 weeks after surgery). In contrast to patients in group 2 and
group 3, patients in group 4 did not report a decrease in pain
intensity during the first 6 weeks postoperatively; they reported
a neutral or positive pain slope and continued to experience pain
12 months after surgery.
Results also showed that 6 weeks after surgery, patients in
group 4 had significantly higher pain scores compared with
Table 4
Pain trajectories model descriptions and goodness of fit
indicators.
Model Number of
trajectories
Role of
baseline pain
Quadratic slope AIC
Model 1 3 Time 0 No 3929.81
Model 2 3 Time 0 Yes 3760.60
Model 3 3 Predictor No 2885.20
Model 4 3 Predictor Yes 2776.25
Model 5 4 Time 0 No 3914.35
Model 6 4 Time 0 Yes 3748.13
Model 7 4 Predictor No 2877.86
Model 8 4 Predictor Yes 2772.27
AIC, Akaike Information Criterion (lower values represent a better fit).
Table 5
Pain trajectories model descriptions and goodness of fit indicators.
Slopes Predicted values
Trajectory group n Intercept Linear Quadratic 4 d 6 wk 3 mo 12 mo
1 27 8.663 20.088 20.031 8.65 8.46 8.12 3.14
2 66 7.816 22.211 0.138 7.49 4.81 2.43 1.16
3 60 9.834 23.072 0.195 9.38 5.66 2.37 1.05
4 15 9.102 20.287 0.031 9.06 8.74 8.52 10.12
March 2015·Volume 156·Number 3 www.painjournalonline.com 465
  Copyright  2015 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.
patients in the other 3 groups, suggesting that by the end of the
acute postoperative period, patients with a neutral or positive pain
slope (1) experience higher levels of pain and (2) will continue to
experience this level of pain 12 months after surgery. These
results are consistent with a recent study of CPSP in children in
which pain intensity and unpleasantness scores at 2 weeks after
surgery predicted who would go on to develop CPSP at the
12-month follow-up.46 Designing interventions for patients with
a neutral or positive pain slope in the first few weeks after surgery
could potentially prevent these patients with acute pain from
transitioning into CPSP.
Patients in group 4 did not differ significantly from patients in
groups 1 and 3 on functional outcome measures or on most
psychological variables preoperatively; however, they had poorer
lower-extremity functioning, higher levels of anxiety, higher levels
of functioning difficulty, and walked a shorter distance on the
6-minute walk test compared with patients in group 2. These
results suggest that in addition to levels of preoperative pain,
other preoperative functional and psychological variables
influence the pain reports of patients postoperatively and their
risk of developing CPSP.
Results of this study failed to show that age or gender is a risk
factor for persistent postsurgical pain. This contrasts with other
studies, which found that younger age and female gender are risk
factors for the development of CPSP and persistent opioid use
greater than 3 months after major surgery.19 Results from this
study are consistent with a prospective study of TKA, however,
showing that neither age nor gender is associated with CPSP
after TKA.11
Patients in group 4 not only reported higher levels of pain
12 months after surgery compared with patients in the other
3groupsbut also showeda lower level of lower-extremity functioning
Figure 3.Results of pain trajectories analysis showed 4different subgroups of patients. Group 1 (n5 27), high baseline pain early and late decrease group; group 2
(n 5 66), low baseline pain gradual decrease group; group 3 (n 5 60), high baseline pain gradual decrease group; group 4 (n 5 15), high pain group.
Table 6
Mean (SD) values and statistical differences in psychological and functional outcomes at baseline and 12mo after surgery based
on pain trajectory class membership.
Baseline 12 mo
Group 1 Group 2 Group 3 Group 4 Sig* Group 1 Group 2 Group 3 Group 4 Sig*
Age 60.93 (6.9) 63.97 (5.8) 62.22 (7.5) 64.47 (7.2) NS
WOMAC–Pain 13.00 (2.7) 6.86 (1.6) 11.40 (1.9) 10.53 (2.6) 1-4 3.35 (2.4) 1.23 (1.5) 1.23 (1.5) 10.27 (2.4) 1-4
2-4 2-4
3-4
WOMAC–stiffness 5.30 (1.8) 3.71 (1.5) 5.15 (1.2) 4.13 (1.6) NS 1.82 (1.5) 1.24 (1.2) 1.26 (1.4) 3.63 (1.6) 1-4
2-4
3-4
WOMAC–difficulty 41.70 (11.1) 25.95 (8.7) 47.51 (8.7) 36.60 (8.7) 2-4 14.00 (10.2) 5.23 (6.4) 5.00 (6.3) 32.18 (12.1) 1-4
2-4
3-4
HADS-D 4.44 (2.4) 3.74 (2.5) 4.82 (2.6) 4.87 (2.8) NS 4.12 (2.9) 1.90 (1.8) 2.17 (2.6) 5.64 (4.3) NS
HADS-A 6.74 (2.9) 4.82 (3.0) 6.00 (3.2) 7.60 (3.3) 2-4 5.59 (3.8) 2.90 (2.7) 3.20 (2.30 5.45 (4.8) NS
LEFS 21.41 (11.1) 35.02 (9.8) 26.05 (1.02) 25.94 (9.7) 2-4 33.69 (15.4) 16.23 (11.0) 18.37 (13.7) 40.02 (17.8) 2-4
3-4
PDI 17.00 (15.4) 4.44 (7.9) 6.30 (11.0) 24.18 (19.1) 2-4
TUG–Time 12.79 (4.5) 11.16 (3.7) 13.27 (5.7) 13.60 (2.9) NS
Stairs–Time 26.47 (14.1) 16.90 (5.9) 23.20 (10.2) 27.02 (12.9) 2-4
Walk test–distance 318.85 (143.1) 409.32 (110.8) 323.53 (139.5) 323.71 (141.8) NS
Knee flexion 108.35 (15.6) 116.64 (12.9) 111.13 (18.5) 109.86 (15.92) NS
Knee extension 2.70 (3.3) 3.43 (4.0) 2.80 (3.5) 3.07 (4.6) NS
* Statistically significant differences between pain trajectory groups using Bonferroni post hoc test. Only differences between group 4 and the other 3 groups were examined.
HADS-Anxiety, Hospital Anxiety and Depression Scale—Anxiety Subscale; HADS-D, Hospital Anxiety and Depression Scale—Depression Subscale; LEFS, lower extremity function scale; NS, not significant; PDI, Pain Disability
Index; TUG, timed get up and go test; WOMAC–difficulty, Western Ontario and McMaster Universities Osteoarthritis Index—difficulty subscale; WOMAC–Pain, Western Ontario and McMaster Universities Osteoarthritis
Index—Pain subscale; WOMAC–stiffness, Western Ontario and McMaster Universities Osteoarthritis Index—stiffness subscale.
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and reported higher levels of stiffness, functioningdifficulty, andpain-
related disability. These results suggest that these patients recover
poorly from the surgery in other domains of life besides pain. It is
unclear, however, whether the stiffness and functioning difficulty
reported are a consequence of the pain experiencedorwhether they
contribute to the development of CPSP.
It is important to note that our cohort identified 15/168 (9%)
group 4 patients (ie, those who remained in the study until POD4)
who could potentially benefit from more aggressive therapies
perioperatively. Recently, a growing body of evidence suggests
that fitness improvements achieved through total-body pre-
operative physical conditioning can significantly impact peri- and
postoperative health.54 Future studies may consider identifying
patients with high pain and poor preoperative function (group 4)
and then tailor prehabilitation programs toward improving
function and decreasing pain in an attempt to improve baseline
function and potentially modify/improve their postoperative pain
trajectory.
5. Limitations
First, patients in this study participated in a randomized controlled
trial of the efficacy of gabapentin in reducing postoperative pain.18
Results of this RCT found that gabapentin improved early
in-hospital knee function, although this early gain in function did
not translate into improved functional status after hospital
discharge.18 Although no group differences were found in pain
trajectories between patients who received gabapentin vs
placebo, it would be important to replicate the current findings
with a homogenous sample of patients receiving uniform post-
operative care. Second, sample size of this study did not allow for
the examination of the relationships between pain trajectories and
functional and psychological variables within the GMM. It would
be interesting for future studies to examine how these additional
variables can directly impact pain trajectories. Third, no intra-
operative data (eg, surgeon who performed TKAs, length of
surgery, technical difficulties during surgery) were collected and
as such these variables could not be controlled for in the
trajectory model.
In summary, results showed that 4 different pain trajectories
could be identified, one of which includes approximately 9%
of patients who display a neutral or positive pain slope over
the first year after TKA. Results suggest that a neutral or
positive pain slope in the first few weeks after surgery leads
to the continuation of the pain experience and the development
of CPSP. In addition to levels of acute postoperative pain, levels
of preoperative pain can also influence patients’ pain trajectories.
Future research directions include replication of this pain trajectory
model in other postoperative populations and examination of
functional and psychological variables that can influence pain
trajectories. Furthermore, early identification of patients with a flat
pain trajectory in the weeks after surgery could lead to the
development of programs that are aimed at aggressively in-
tervening inanattempt todecrease thedevelopment of apersistent
postsurgical pain problem.
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